PubMed Health⌕ Search

Biomedical subjects

Barry Alan Kramer

Publications and source records attributed to Barry Alan Kramer.

7 recordsLinked to original sources

Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes.

OBJECTIVE: To determine the effects of ECT combined with antipsychotic medication therapy on psychopathology, quality of life, and social functioning in patients with refractory schizophrenia. METHOD: An open acute (Phase I) and maintenance (Phase II) study of the combination of ECT and flupenthixol in the treatment of 46 schizophrenic patients who were nonresponsive to antipsychotic medication from at least two different classes. Scales used: the Brief Psychiatric Rating Scale (BPRS), the Quality of Life Scale (QLS), Social and Occupational Functioning Assessment Scale (SOFAS), Global Assessment of Functioning (GAF), and Mini-Mental State Exam (MMSE). The duration of Phase II was 1 year. RESULTS: In Phase I, there were marked reductions in the BPRS scores, and substantial increases in the QLS, SOFAS, GAF, and MMSE scores. During Phase II, the BPRS negative symptoms worsened but remained improved from baseline. Changes in other outcome measures were negligible. CONCLUSION: ECT and MECT combined with flupenthixol were effective in improving psychopathology in patients refractory to antipsychotic medication alone. Ratings of psychopathology, quality of life, and social functioning all improved in Phase I and were generally sustained during Phase II in patients who had remitted.

Acute Disease↗

Anticholinergics and ECT.

Anticholinergic medication is commonly used prior to anesthetizing patients for electroconvulsive therapy (ECT). Its routine use is the subject of ongoing controversy. This article reviews how anticholinergics came to be used with ECT and the work supporting or refuting their routine use. The route of administration and their use with beta blockers are reviewed. Atropine, glycopyrrolate, and scopolamine are compared. While acknowledging the pau-city of carefully controlled trials with large numbers of patients, the routine use of intravenous atropine prior to administering ECT is recommended unless specifically contraindicated.

Journal Article↗

Atypical Cholinesterase and Prolonged Apnea During Electroconvulsive Therapy.

A 62-year-old man developed prolonged apnea during ECT with succinylcholine. He was found to have atypical cholinesterase. Subsequent ECTs were given using atracurium as the muscle relaxant. A review of the finding of atypical cholinesterase is presented along with a discussion of the use of atracurium.

Journal Article↗

A Survey of ECT Use in Asia.

A questionnaire was mailed to 100 hospitals involved with medical education in 13 Asian countries. Replies were received from 36. The authors compare electroconvulsive therapy (ECT) usage in Asian countries with that in the United States. Marked similarities occur in response rate, number of treatments, and treatment techniques. Differences in anesthesia are associated with a seemingly higher incidence of injury. Bilateral electrode placement and maintenance ECT are widely used.

Journal Article↗

Maintenance Electroconvulsive Therapy in Clinical Practice.

Five cases of maintenance electroconvulsive therapy (ECT) are reviewed to illustrate the indications for this treatment. The patients' conditions described are consistent with the recommendations of the 1990 American Psychiatric Association Task Force on ECT. Guidelines and examples for selecting patients for maintenance ECT are presented, but when to preferentially treat with continuation pharmacotherapy versus ECT requires further study. Optimal dosing, interval between treatments, and duration of treatment remain questions. The logistics of the treatment are briefly presented and should be easily incorporated into most ECT programs.

Journal Article↗

Maintenance ECT: A Survey of Practice (1986).

A questionnaire on the use of maintenance or continuation ECT was mailed to 173 practitioners of ECT. Of 86 respondents, 51 reported they used maintenance therapy, and 35 did not. Users came from 24 states, with five states accounting for more than half. Of practitioners giving maintenance ECT, each treated a median of three patients annually between 1981 through 1984, with a range from zero to "thousands." Frequency of treatments is determined empirically, with most treatments given monthly. Memory impairment is the most commonly cited risk. Depression is the diagnosis in 90% of the patients, with schizoaffective, schizophrenic, and manic patients equally comprising the remainder of the patients. The longest series reported for any one patient is 2,400 treatments.

Journal Article↗

Practice Patterns of Electroconvulsive Therapy: A California Perspective (1984).

The sixty-five California hospitals administering electroconvulsive therapy (ECT) during 1984 were surveyed regarding ECT practices to develop data on the community standard of care. Usable data were obtained from 58 hospitals. In each facility two psychiatrists usually administered ECT, including one psychiatrist who received credentials in or after 1977. Thirty-four brief-pulse and 43 sine-wave machines were in use. Treatment was performed on the psychiatric unit in 41.4% of the hospitals, in the operating room or the recovery room in 50% of the hospitals, and in other locations in 8.6% of the hospitals. The psychiatrist administered the anesthesia in 12 (21%) of the hospitals. Unilateral electrode placement was used in 42% of patients. The use of anesthetic agents, ancillary equipment, and staffing patterns is reviewed.

Journal Article↗